33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • The role of microRNAs in the pathogenesis of Erdheim-Chester disease and their potential use as biomarkers for diagnosis and prognosis of the disease
    Meeting Abstract

    Weissman, R.; Pilar, N.; Durham, B. H.; Ki, M.; Mazor, R. D.; Abdel-Wahab, O. I.; Shomron, N.; Shpilberg, O.; Diamond, E. L.; Rokah, O.
    Blood (2018)

    Fulltext@MSK | Save
  • Mutations in the RNA splicing factor SF3B1 promote transformation through MYC stabilization
    Meeting Abstract

    Yoshimi, A.; Liu, Z.; Wang, J.; Cho, H.; Lee, S. C.; Ki, M.; Bitner, L. E.; Chu, T.; Mato, A. R.; Ruvolo, P. P.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Slit-Robo pathway is clinically relevant and may represent a potential target in acute promyelocytic leukemia
    Meeting Abstract

    Weinhauser, I.; Pereira-Martins, D. A.; Ortiz, C.; Schiavinato, J. L.; Bonaldo, C.; Koury, L. C.; Wagatsuma, V. M. D.; Melo, R. A. M.; Bittencourt, R.; Pagnano, K. B.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Front-line ibrutinib treatment is associated with longer time to next treatment, net total cost reduction, and lower healthcare resource utilization compared to chemoimmunotherapy in patients with chronic lymphocytic leukemia
    Meeting Abstract

    Wang, S.; Emond, B.; Romdhani, H.; Lefebvre, P.; Sundaram, M.; Mato, A. R.
    Blood (2018)

    Fulltext@MSK | Save
  • Myeloproliferative neoplasm (MPN) blastic transformation occurs at the level of hematopoietic stem cells
    Meeting Abstract

    Wang, X.; Hu, C. S.; Tripodi, J.; Najfeld, V.; Petersen, B.; Rampal, R. K.; Farnoud, N.; Famulare, C.; Mascarenhas, J.; Hoffman, R.
    Blood (2018)

    Fulltext@MSK | Save
  • Cardiovascular mortality among CML patients in the pre-TKI and TKI eras: A SEER analysis 1992-2004
    Meeting Abstract

    Wang, Q.; Zhang, Y.; Yue, B.; Zhang, Y.; Jiang, C.; Perimbeti, S.; Mauro, M. J.
    Blood (2018)

    Fulltext@MSK | Save
  • Ratify (Alliance 10603): Prognostic impact of FLT3 tyrosine kinase domain (TKD) and NPM1 mutation status in patients with newly diagnosed acute myeloid leukemia (AML) treated with midostaurin or placebo plus standard chemotherapy
    Meeting Abstract

    Voso, M. T.; Larson, R. A.; Prior, T.; Marcucci, G.; Jones, D.; Krauter, J.; Heuser, M.; Lavorgna, S.; Nomdedeu, J.; Geyer, S. M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • The role of HLA-E, polymorphism in acute leukemia patients receiving a 10/10 HLA matched unrelated HSCT
    Meeting Abstract

    Tsamadou, C.; Wang, T.; Furst, D.; Lee, S. J.; Spellman, S. R.; Fleischhauer, K.; Hsu, K. C.; Paczesny, S.; Verneris, M. R.; Neuchel, C.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy
    Meeting Abstract

    Talati, C.; Goldberg, A. D.; Przespolewski, A.; Chan, O.; Al Ali, N.; Famulare, C.; Sallman, D. A.; Padron, E.; Kuykendall, A.; List, A. F.; more...
    Blood (2018)

    Fulltext@MSK | Save